A. Wollenberg, M. Cork, C.-H. Hong, A. Kurbasic, E. Vacko, and A. Paller, “Progressive and Sustained Disease Control in Patients with Atopic Dermatitis (AD) Aged 12–17 Years Treated with Tralokinumab for 52 Weeks”, J of Skin, vol. 8, no. 2, p. s377, Mar. 2024.